X0306 4 2018-10-22 0 0001616314 MedEquities Realty Trust, Inc. MRT 0001427430 BlueMountain Capital Management, LLC 280 PARK AVENUE, 12TH FLOOR NEW YORK NY 10017 1 0 0 0 Common Stock 2018-10-22 4 S 0 5000 8.65 D 2085061 I Footnotes Common Stock 2018-10-22 4 S 0 463 8.70 D 2084598 I Footnotes Common Stock 2018-10-23 4 S 0 5000 8.40 D 2079598 I Footnotes Common Stock 2018-10-23 4 S 0 3733 8.42 D 2075865 I Footnotes The filing of this Form 4 shall not be construed as an admission that BlueMountain Capital Management, LLC ("BMCM") is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any of the shares of Common Stock, par value $0.01 per share (the "Common Stock"), of MedEquities Realty Trust, Inc. (the "Issuer"). Pursuant to Rule 16a-1(a)(4) of the Exchange Act, BMCM disclaims such beneficial ownership, except to the extent of its pecuniary interest. BMCM is the investment manager of Blue Mountain Credit Alternatives Master Fund L.P., BlueMountain Guadalupe Peak Fund L.P. ("Guadalupe"), BlueMountain Credit Opportunities Master Fund I L.P., BlueMountain Strategic Credit Master Fund L.P. ("Strategic") and BlueMountain Montenvers Master Fund SCA SICAV-SIF (collectively, the "Funds"), which are the direct beneficial owners of 2,075,865 shares of Common Stock in the aggregate. BMCM, although it directs the voting and disposition of the Common Stock held by the Funds, only receives an asset-based fee relating to the Common Stock held by the Funds. On October 22, 2018, Strategic sold 3,130 and 290 shares of Common Stock for $8.65 and $8.70 per share, respectively, and Guadalupe sold 1,870 and 173 shares of Common Stock for $8.65 and $8.70 per share, respectively. On October 23, 2018, Strategic sold 3,130 and 2,337 shares of Common Stock for $8.40 and $8.42 per share, respectively, and Guadalupe sold 1,870 and 1,396 shares of Common Stock for $8.40 and $8.42 per share, respectively. Elliot Mandelbaum, a former employee of BMCM, serves as a member of the board of directors of the Issuer as the representative of BMCM. In connection therewith, BMCM may be deemed to be a director by deputization of the Issuer solely for purposes of Section 16(a) of the Exchange Act. As a result, BMCM is listed a "Reporting Person" in Item 1 and the "Director" box is marked in Item 5 of this Form 4. BlueMountain Capital Management, LLC, By: /s/ Eric M. Albert, Chief Compliance Officer 2018-10-24